跳至主要内容
临床试验/EUCTR2021-005404-36-Outside-EU/EEA
EUCTR2021-005404-36-Outside-EU/EEA进行中(未招募)1 期

A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Japanese Pediatric Subjects with Short Bowel Syndrome Who Completed SHP633-302

Shire0 个研究点开始时间: 2021年10月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Shire

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Informed consent by a parent or guardian prior to any study-related procedures.
  • - When applicable, informed assent (as deemed appropriate by the Institutional Review Board [IRB]) by the participant prior to any study-related procedures.
  • - Participant completed Study SHP633-302 (NCT02980666).
  • - Participant (and/or parent/guardian) understands and is willing and able to fully adhere to study requirements as defined in this protocol.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 9
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • There are no exclusion criteria for this study.

研究者

发起方
Shire

相似试验

进行中(未招募)
1 期
A long term extension study looking at the efficacy and safety of teduglutide in paediatric patients suffering from short bowel syndrome who took part in study TED-C14-006 or SHP633-301Short Bowel Syndrome
EUCTR2016-000849-30-FIShire Human Genetic Therapies, Inc.50
进行中(未招募)
1 期
A long term extension study looking at the efficacy and safety of teduglutide in paediatric patients suffering from short bowel syndrome who took part in study TED-C14-006MedDRA version: 20.0Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersShort Bowel Syndrome
EUCTR2016-000849-30-BEShire Human Genetic Therapies, Inc.61
进行中(未招募)
1 期
A long term extension study looking at the efficacy and safety of teduglutide in paediatric patients suffering from short bowel syndrome who took part in study TED-C14-006MedDRA version: 20.0Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersShort Bowel Syndrome
EUCTR2016-000849-30-ITShire Human Genetic Therapies, Inc.34
进行中(未招募)
1 期
A long term extension study looking at the efficacy and safety of teduglutide in paediatric patients suffering from short bowel syndrome who took part in study TED-C14-006 or SHP633-301MedDRA version: 20.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersShort Bowel Syndrome
EUCTR2016-000849-30-FRShire Human Genetic Therapies, Inc.61
进行中(未招募)
1 期
A long term extension study looking at the efficacy and safety of teduglutide in paediatric patients suffering from short bowel syndrome who took part in study TED-C14-006 or SHP633-301MedDRA version: 20.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersShort Bowel Syndrome
EUCTR2016-000849-30-GBShire Human Genetic Therapies, Inc.50